Short interest in ARS Pharmaceuticals Inc (NASDAQ:SPRY) increased during the last reporting period, rising from 11.92M to 12.60M. This put 24.49% of the company's publicly available shares short.

Short interest for ARS Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of ARS Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 928.51K shares traded per day, it would take 13.57 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.